U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 29 results

Status:
US Approved Rx (2018)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secr...
Status:
US Approved Rx (2013)
First approved in 1999

Class (Stereo):
CHEMICAL (ABSOLUTE)



Doxercalciferol is a synthetic vitamin D2 analog that undergoes metabolic activation in vivo to form 1α,25-dihydroxyvitamin D2 (1α,25-(OH)2D2), a naturally occurring, biologically active form of vitamin D2. Doxercalciferol is indicated for the treatm...
Status:
US Approved Rx (2016)
First approved in 1991

Class (Stereo):
CHEMICAL (ABSOLUTE)



Simvastatin is a HMG-CoA Reductase Inhibitor that is FDA approved for the treatment of hypercholesterolemia and for the reduction in the risk of cardiac heart disease mortality and cardiovascular events. It reduces levels of "bad" cholesterol (low-de...
Status:
US Approved Rx (2007)
First approved in 1991

Class (Stereo):
CHEMICAL (ABSOLUTE)



Histrelin is a gonadotropin releasing hormone (GnRH) agonist that acts as a potent inhibitor of gonadotropin when administered as an implant that delivers continuous therapeutic doses. Following an initial stimulatory phase with increased circulating...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Clometherone is an investigational derivative of progesterone, possessing antiestrogen and antiandrogen activities. It was developed by Eli Lilly in the 1960s and was found to significantly suppress the estrone induced uterine hypertrophy in mice at ...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Spirorenone is an androstadienone derivative patented by Schering A.-G as a highly effective aldosterone antagonist. Spirorenone is 8.6 times as potent as spironolactone, but showed a lower affinity for the mineralocorticoid receptors. In phase I cli...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Terlakiren (also known as CP80794) is a cysteinamide derivative patented by Pfizer Inc. as potent renin inhibitor. Terlakirens inhibitory potency against plasma renin of guinea pigs, dogs, and monkeys ranges from 0.3 to 0.7 nM. In preclinical models...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Spiroxasone is a synthetic, steroidal antimineralocorticoid of the spirolactone group patented by Merck & Co., Inc. as a diuretic and antihypertensive agent. Spiroxasone acts as potent aldosterone antagonists in animals and humans.
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)


Lexacalcitol (KH1060) is over 100 times more active than 1alpha,25-dihydroxyvitamin D3 and is of potential interest in the treatment of psoriasis and other diseases characterized by accelerated cell growth and T lymphocyte activation, which was studi...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Cinanserin is a 5-hydroxytryptamine receptor antagonist; it shows a low affinity to 5-HT2b binding sites and a 4-to 10-fold lower affinity to 5-HT2c receptor binding sites than for 5-HT2a sites. Nevertheless, at concentrations normally used 5-HT2c rece...